Obstructive lower urinary tract symptoms correlate with erectile dysfunction

Urology

Volumn 63, Issue 6, 2004, Pages 1148-1152

  Elliott, Sean P ^b   Gulati, Mittul ^b   Pasta, David J ^b   Spitalny, G Mark ^b   Kane, Christopher J ^b   Yee, Rita ^b   Lue, Tom F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; AGED; ANAMNESIS; ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DEMOGRAPHY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; ERECTILE DYSFUNCTION; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIPLE REGRESSION; PRIORITY JOURNAL; QUESTIONNAIRE; RESIDUAL URINE; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; URINARY TRACT OBSTRUCTION; UROFLOWMETRY;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; COMORBIDITY; DEPRESSION; DIABETES MELLITUS, TYPE 2; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUESTIONNAIRES; REGRESSION ANALYSIS; SAN FRANCISCO; SMOKING; URINARY BLADDER NECK OBSTRUCTION; URODYNAMICS; VETERANS;

EID: 2942612998     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2004.01.039     Document Type: Article

References (20)

1. Feldman H.A., Goldstein I., Hatzichristou D.G., et al. Impotence and its medical and psychosocial correlates results of the Massachusetts Male Aging Study. J Urol. 151:1994;54-61
2. DaSilva F.C. Benign prostatic hyperplasia natural evolution versus medical treatment. Eur Urol. 32:(suppl 2):1997;34-37
3. Namasivayam S., Minhas S., Brooke J., et al. The evaluation of sexual function in men presenting with symptomatic benign prostatic hyperplasia. Br J Urol. 82:1998;842-846
4. Frankel S.J., Donovan J.L., Peters T.I., et al. Sexual dysfunction in men with lower urinary tract symptoms. J Clin Epidemiol. 51:1998;677-685
5. Blanker M.H., Bohnen A.M., Groeneveld F.P.M.J., et al. Correlates for erectile and ejaculatory dysfunction in older Dutch men a community-based study. J Am Geriatr Soc. 49:2001;436-442
6. Rosen R., Altwein J., Boyle P., et al. Lower urinary tract symptoms and male sexual dysfunction the multinational survey of the aging male (MSAM-7). Eur Urol. 44:2003;637-649
7. Leliefeld H.H.J., Stoevelaar H.J., McDonnell J. Sexual function before and after various treatments for symptomatic benign prostatic hyperplasia. BJU Int. 89:2002;208-213
8. Brookes S.T., Donovan J.L., Peters T.J., et al. Sexual dysfunction in men after treatment for lower urinary tract symptoms evidence from randomized controlled trial. BMJ. 324:2002;1059-1061
9. Arai Y., Aoki Y., Okubo K., et al. Impact of interventional therapy for benign prostatic hyperplasia on quality of life and sexual function a prospective study. J Urol. 164:2000;1206-1211
10. Gacci M., Bartoletti R., Figioli S., et al. Urinary symptoms, quality of life and sexual function in patients with benign prostatic hypertrophy before and after prostatectomy. BJU Int. 91:2003;196-200
11. Green J.S.A., Holden S.T.R., Bose P., et al. An investigation into the relationship between prostate size, peak urinary flow rate and male erectile dysfunction. Int J Impot Res. 13:2001;322-325
12. Goldstein I. The mutually reinforcing triad of depressive symptoms, cardiovascular disease, and erectile dysfunction. Am J Cardiol. 86:(suppl):2000;41F-45F
13. Wessells H., Roy J., Bannow J., et al. Incidence and severity of sexual adverse experiences in finasteride and placebo-treated men with benign prostatic hyperplasia. Urology. 61:2003;579-584
14. Lepor H., Willoford W.O., Barry M.J., et al. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. N Engl J Med. 335:1996;533-539
15. Kirby R.S., Roehrborn C., Boyle P., et al. Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia the prospective European doxazosin and combination therapy (PREDICT) trial. Urology. 61:2003;119-126
16. Sairam K., Kulinskaya E., McNicholas T.A., et al. Sildenafil influences lower urinary tract symptoms. BJU Int. 90:2002;836-839
17. MacFarlane G.J., Botto H., Sagnier P.P., et al. The relationship between sexual life and urinary condition in the French community. J Clin Epidemiol. 49:1996;1171-1176
18. Rosen R.C., Cappelleri J.C., Smith M.D., et al. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 11:1999;319-326
19. Barry M.J., Fowler F.J. Jr, O'Leary M.P., et al. The American Urological Association Symptom Index for benign prostatic hyperplasia. J Urol. 148:1992;1549-1557
20. Khan M.A., Dashwood M.R., Thompson C.S., et al. Down-regulation of endothelin-B receptor sites in cavernosal tissue of a rabbit model of partial bladder outlet obstruction potential clinical relevance. World J Urol. 17:1999;290-295